glucosamine has been researched along with Chronic Hepatitis C in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruguera, M; Cerda, C; Parés, A | 1 |
El-mezayen, HA; Shiha, GE; Toson, el-SA | 1 |
Abo-Seif, MA; Attallah, AM; El-Waseef, AM; Omran, MM; Shiha, GE; Toson, el-SA | 1 |
3 other study(ies) available for glucosamine and Chronic Hepatitis C
Article | Year |
---|---|
Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Chondroitin Sulfates; Dietary Supplements; Female; Glucosamine; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Risk Factors; Surveys and Questionnaires; Young Adult | 2013 |
Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
Topics: Acetylglucosaminidase; Adult; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Biopsy; Decision Support Techniques; Discriminant Analysis; Egypt; Female; Ferritins; Glucosamine; Glucuronidase; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Linear Models; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Assessment; Risk Factors; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Unnecessary Procedures | 2013 |
Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection.
Topics: Adult; Biopsy; Discriminant Analysis; Female; Glucosamine; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Liver Cirrhosis; Male; Middle Aged; ROC Curve | 2006 |